4.5 Article

Early rituximab treatment is associated with increased and sustained remission in pemphigus patients: A retrospective cohort of 99 patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Treatment of Pemphigus with Rituximab: Real-Life Experience in a Cohort of 117 Patients in Israel

Adi Nosrati et al.

Summary: A combination of rituximab and corticosteroids shows efficacy in inducing remission in most pemphigus patients in real-life settings, with certain patients experiencing relapses. Repeating treatment for relapsed patients can increase remission rates, with adverse events similar to previous studies.

DERMATOLOGY (2021)

Article Medicine, General & Internal

Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris

V. P. Werth et al.

Summary: In a 52-week trial, rituximab was found to be superior to mycophenolate mofetil in producing sustained remission of pemphigus vulgaris and in reducing glucocorticoid use. However, there were more serious adverse events in the rituximab group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Dermatology

Factors Associated With Complete Remission After Rituximab Therapy for Pemphigus

Carolyn J. Kushner et al.

JAMA DERMATOLOGY (2019)

Article Dermatology

Comparing early and late treatments with rituximab in pemphigus vulgaris: which one is better?

Kamran Balighi et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2019)

Review Medicine, General & Internal

The Genetics of Pemphigus Vulgaris

Dan Vodo et al.

FRONTIERS IN MEDICINE (2018)

Article Dermatology

Epidemiological data of 290 pemphigus vulgaris patients: a 29-year retrospective study

Sharon Baum et al.

EUROPEAN JOURNAL OF DERMATOLOGY (2016)

Article Dermatology

Grading criteria for disease severity by pemphigus disease area index

Tomoko Shimizu et al.

JOURNAL OF DERMATOLOGY (2014)

Article Dermatology

Durable Remission of Pemphigus With a Fixed-Dose Rituximab Protocol

Kara Heelan et al.

JAMA DERMATOLOGY (2014)

Article Dermatology

Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: A retrospective study of 47 patients

Yael A. Leshem et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)

Review Dermatology

Rituximab in the Treatment of Pemphigus Vulgaris

Labib R. Zakka et al.

DERMATOLOGY AND THERAPY (2012)

Article Dermatology

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

Dedee E. Murrell et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)

Article Medicine, General & Internal

A single cycle of rituximab for the treatment of severe pemphigus

Pascal Joly et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Immunology

The immunogenetics of pemphigus vulgaris

E Gazit et al.

AUTOIMMUNITY REVIEWS (2005)